Related Experiment Video
Updated: Feb 28, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
Iguratimod suppresses volume-sensitive outwardly rectifying anion channels via arachidonic acid accumulation
Takahiro Shimizu1, Shiho Sumiyoshi1, Kyosuke Fujita2
1Department of Pharmaceutical Physiology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.
Abstract:
Iguratimod, an anti-rheumatic agent, is known to suppress the production of inflammatory cytokines and inhibit B-cell proliferation. Recent studies have implicated volume-sensitive outwardly rectifying (VSOR) Cl- channels in the regulation of immune responses. In this study, we investigated whether iguratimod modulates VSOR Cl- currents using whole-cell patch-clamp recordings in human embryonic kidney 293T cells. Iguratimod inhibited hypotonicity-induced VSOR Cl- currents in a concentration-dependent manner. Notably, celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, also significantly suppressed these currents. Furthermore, pyrrophenone, a phospholipase A2 inhibitor, attenuated the inhibitory effect of iguratimod on VSOR Cl- currents. Under hypotonic conditions, the levels of free arachidonic acid were significantly elevated in the presence of iguratimod and celecoxib. These findings suggest that iguratimod increases free arachidonic acid levels by inhibiting COX-2 during osmotic cell swelling, thereby suppressing VSOR Cl- channel activity. This suppression of VSOR Cl- channel activity may present one of the mechanisms through which iguratimod exerts its anti-inflammatory effects in rheumatic diseases.
More Related Videos
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
09:59Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-Protein Gated Ion Channels
Sensory...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...